rs3184504 — SH2B3 R262W

SH2B3 R262W — The Pleiotropic Inflammation Dial

SH2B3 (also known as LNK) encodes an adaptor protein that acts as a negative regulator of cytokine and growth-factor signalling¹¹ negative regulator of cytokine and growth-factor signalling
SH2B3 contains a pleckstrin homology domain and an SH2 domain; it suppresses JAK2, c-kit, MPL, and IL-7R signalling by competing with downstream effectors at phosphotyrosine docking sites. The rs3184504 variant swaps arginine for tryptophan at position 262 in the pleckstrin homology domain, partially disabling this brake. The result is a hypomorphic allele²² hypomorphic allele
a variant that reduces but does not abolish protein function — the protein is still made, but it represses downstream signalling less effectively.

This makes rs3184504 one of the most studied pleiotropic SNPs in the human genome: a single amino acid change³³ single amino acid change
R262W located in exon 3 of SH2B3 on chromosome 12q24 that influences blood pressure, platelet count, eosinophil count, coronary artery disease, type 1 diabetes, and celiac disease — each replicated across multiple large GWAS and validated mechanistically.

The Mechanism

SH2B3 normally dampens the proliferation and activation of hematopoietic progenitor cells and T cells. The R262W change reduces SH2B3's ability to bind membrane phosphoinositides and to suppress JAK/STAT and ERK1/2 cascades⁴⁴ JAK/STAT and ERK1/2 cascades
downstream of cytokine receptors including thrombopoietin receptor MPL, stem-cell factor receptor c-kit, and IL-12 receptor. In blood cells, reduced SH2B3 function leads to expansion of hematopoietic stem cells and enhanced megakaryopoiesis — more platelets and leukocytes. In T cells, the Trp variant is less repressive of IL-12 signalling⁵⁵ less repressive of IL-12 signalling
IL-12 triggers Stat4 phosphorylation and IFNγ production; Trp-SH2B3 suppresses this less effectively than Arg-SH2B3, leading to greater IFNγ output from CD8+ T cells when stimulated.

Knockin mouse studies⁶⁶ Knockin mouse studies
Mice engineered to carry the equivalent Trp substitution exhibit a phenotype similar to full Sh2b3 knockout, confirming R262W is at least a partial loss of function confirm the mechanism: Trp/Trp animals develop approximately 10 mmHg higher systolic blood pressure under chronic angiotensin II challenge, alongside greater renal infiltration by CD8+ T cells, perivascular fibrosis, and albuminuria — a cardiovascular–immune axis linking the variant to hypertension and end-organ damage.

The Evidence

Blood pressure. The Global BPgen consortium⁷⁷ Global BPgen consortium
34,433 Europeans tested for 2.5 million SNPs; SH2B3 reached p = 3×10−18 for diastolic blood pressure identified SH2B3 rs3184504 as one of eight genome-wide-significant blood pressure loci in 2009. The T allele is associated with modestly elevated diastolic and systolic blood pressure across large European cohorts.

Coronary artery disease. A PRISMA-compliant meta-analysis⁸⁸ PRISMA-compliant meta-analysis
12 studies, 25,845 CHD cases and 68,910 controls pooling 25,845 cases and 68,910 controls found OR = 1.12 (95% CI 1.09–1.15) for the T allele overall; OR = 1.13 (1.08–1.18) for myocardial infarction. The association was not significant in Asian populations, consistent with the T allele being extremely rare outside European ancestry.

Cardiac inflammation and fibrosis. Sh2b3-knockout rats develop 2.2-fold greater post-MI fibrosis⁹⁹ 2.2-fold greater post-MI fibrosis
measured by collagen staining and echocardiographic fractional shortening in Sh2b3-KO vs wild-type rats after myocardial infarction and significantly more leukocyte infiltration than wild-type controls, with impaired left-ventricular function — evidence that SH2B3 actively restrains cardiac inflammation after injury.

Atherosclerosis and thrombosis. Using human cord blood, the common TT genotype showed expansion of hematopoietic stem cells¹⁰¹⁰ expansion of hematopoietic stem cells
increased MPL/thrombopoietin signalling, enhanced platelet production and activation, leukocytosis and enhanced megakaryopoiesis; in hypercholesterolaemic mice, LNK deficiency exacerbated both atherosclerotic plaque burden and thrombosis. Eosinophil-specific LNK deficiency promotes arterial thrombosis independently, mediated by eosinophil degranulation onto vessel walls¹¹¹¹ mediated by eosinophil degranulation onto vessel walls
Blood 2024.

Autoimmune disease. In 2008 rs3184504 was identified as a celiac disease risk locus¹²¹² identified as a celiac disease risk locus
Nature Genetics study of 2,410 cases; rs3184504 T allele OR ~1.18 in the first post-HLA celiac GWAS. A 2008 NEJM study confirmed it as one of seven loci shared between type 1 diabetes and celiac disease¹³¹³ seven loci shared between type 1 diabetes and celiac disease
Smyth et al., NEJM 2008, 8,064 T1D patients and 2,828 trios. The same T allele that raises cardiovascular risk also raises autoimmune risk — a genuine trade-off driven by the same underlying mechanism: less immune suppression, more immune activation.

Longevity trade-off. In a UK Biobank PheWAS of 379,758 Europeans¹⁴¹⁴ UK Biobank PheWAS of 379,758 Europeans
phenome-wide association study of 52 aging traits, genotype in Hardy–Weinberg equilibrium (p=0.642), CC homozygotes were 18% more likely to have extremely long-lived parents (OR 1.18, 95% CI 1.07–1.29), with lower blood pressure, fewer cardiovascular events, and lower T1D and hypothyroidism rates. TT homozygotes had modest cancer protection (any cancer OR 0.97) — a biological trade-off between cardiovascular longevity and immune surveillance.

Practical Actions

The T allele increases cardiovascular risk primarily through two channels: elevated blood pressure and a mildly prothrombotic haematological profile (higher platelet counts, higher eosinophils). For TT carriers especially, blood pressure monitoring is the most directly actionable intervention — even a 10 mmHg difference in systolic BP is clinically meaningful for lifetime cardiovascular risk.

On the autoimmune side, the same T allele slightly elevates risk for celiac disease and type 1 diabetes. This is worth knowing if you have unexplained gastrointestinal symptoms or a family history of autoimmune disease.

The dietary pattern most aligned with the biology of this variant is one that specifically targets platelet activation and blood pressure: omega-3 fatty acids reduce platelet aggregation and lower blood pressure, and magnesium and potassium support vasodilation. These are genotype-specific rather than generic because the mechanism is elevated platelet production and impaired T-cell braking — not just general cardiovascular risk.

Interactions

SH2B3 rs3184504 sits in a region of strong linkage disequilibrium on chromosome 12q24 together with ATXN2 and BRAP. Many published studies cannot cleanly separate SH2B3 from ATXN2 associations at this locus; however, functional and knockin evidence supports SH2B3 as the causal gene. The autoimmune associations (PTPN22 rs2476601, CTLA4 rs3087243, HLA-DQA1 rs2187668) operate through partially overlapping T-cell activation pathways. A carrier with both rs3184504 T and rs2476601 A (PTPN22 R620W) has two independent lesions in T-cell braking — one reducing SH2B3 suppression of JAK/STAT, the other disrupting LYP-mediated TCR downregulation. The combined effect on autoimmune risk would be expected to be additive or supra-additive, though direct compound evidence is limited to observational co-occurrence data rather than interaction studies.

Carriers of both rs3184504 TT and rs2476601 AG/AA have two independent T-cell activation-amplifying variants and would benefit from combined autoimmune monitoring — including baseline ANA, RF, anti-CCP, and anti-TPO — given the convergent biology.